<DOC>
	<DOCNO>NCT01685411</DOCNO>
	<brief_summary>This treatment guideline allow routine clinical data collect maintain Oncore ( clinical database ) University Minnesota Blood Marrow Database part historical database maintain department .</brief_summary>
	<brief_title>Busulfan Cyclophosphamide Followed By ALLO BMT</brief_title>
	<detailed_description>This single arm trial evaluate efficacy busulfan cyclophosphamide follow allogeneic hematopoietic stem cell transplant ( HSCT ) treatment hematological malignancy . The intent study provide protocol use unmanipulated allogeneic hematopoietic stem cell relate unrelated donor common preparative regimen . Results compare historical control .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<criteria>Diagnosis acute lymphoblastic leukemia ( ALL ) , acute myeloid leukemia ( AML ) myelodysplastic syndrome ( MDS ) current complete remission meet one following : &lt; 45 year age least 6 month initial hematopoietic stem cell transplant ( HSCT ) &lt; 45 year age receive sufficient radiation treatment ineligible total body irradiation ( TBI ) contain preparative therapy Karnofsky performance status &gt; 70 % &lt; 16 year age , Lansky play score &gt; 50 Adequate major organ function include : cardiac : leave ventricular ejection fraction &gt; 45 % echocardiogram ( ECHO/MUGA ) renal : creatinine clearance &gt; 40 mL/min/1.73m^2 hepatic : clinical evidence hepatic failure ( e.g. , coagulopathy , ascites ) An acceptable source stem cell accord current University Minnesota Bone Marrow Transplant program guideline . Acceptable stem cell source include : HLAmatched relate unrelated donor bone marrow ( 6/6 5/6 antigen match ) HLAmatched relate unrelated donor peripheral blood stem cell related single double unrelated donor umbilical cord blood ( 6/6 , 5/6 4/6 match ) Women childbearing age must negative pregnancy test sexually active participant must agree use effective contraception study treatment Written consent ( adult parent/guardian ) eligible TBI contain preparative regimen active uncontrolled infection within one week study enrollment pregnant lactate female</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>